NCT00217516View on ClinicalTrials.gov

Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

February 29, 2008

Study Completion Date

October 31, 2008

Conditions
Prostate Cancer
Interventions
DRUG

selenium

Given orally

OTHER

placebo

Given orally

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT00217516 - Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer | Biotech Hunter | Biotech Hunter